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Abstract
Background: Norepinephrine (NE), a classic neurotransmitter in the sympathetic nervous system, induces
vasoconstriction of canine isolated mesenteric vein that is accompanied by a sustained membrane depolarization.
The mechanisms underlying the NE-elicited membrane depolarization remain undefined. In the present study we
hypothesized that phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) are involved in the electrical
field stimulation (EFS)-induced slow membrane depolarization (SMD) in canine isolated mesenteric vein. EFS (0.1–
2 Hz, 0.1 ms, 15V, 10 s)-induced changes in the membrane potential were recorded with a conventional
intracellular microelectrode technique and evaluated in the absence and presence of inhibitors of neuronal
activity, α -adrenoceptors, membrane ion channels, PI3K, inositol 1,4,5-triphosphate (InsP3) receptors, and PKC.
Activation of PI3Kγ  and PKCζ  in response to exogenous NE and clonidine in the absence and presence of
receptor and kinase inhibitors were also determined.
Results: Contractile responses to NE and clonidine (0.05 – 10 µM) were significantly diminished in the presence
of yohimbine (0.1 µM). Exogenous NE (0.1 µM) and clonidine (1 µM) elicited SMD. The resting membrane
potential of canine mesenteric vein smooth muscle cells was -68.8 ± 0.8 mV. EFS elicited a biphasic depolarization
comprised of excitatory junction potentials and SMD that are purinergic and adrenergic in nature, respectively.
The magnitude of the SMD in response to EFS at 0.5 Hz was 9.4 ± 0.7 mV. This response was reduced by 65–
98% by the fast Na+ channel inhibitor tetrodotoxin (1 µM), by the inhibitor of N-type Ca2+ channels ω -conotoxin
GVIA (5 nM), the non-selective α -adrenoceptor blocker phentolamine (1 µM), the selective α 2-adrenoceptor
blocker yohimbine (0.1 µM), the ion channel inhibitors niflumic acid (NFA, 100 µM), 5-nitro-2-(3-
phenylpropylamino) benzoic acid (NPPB, 30 µM), 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS, 200
µM), and Gd3+ (30 µM), and the PI3K inhibitors wortmannin (100 nM) and LY-294002 (10 µM). The SMD
remained unchanged in the presence of the L-type Ca2+ channel blocker nicardipine (1 µM) and the InsP3 receptor
blockers 2-aminoethoxydiphenylborate (2APB, 50 µM) and xestospongin C (3 µM). The inhibitor of PKC
chelerythrine (1 µM), but not calphostin C (10 µM), diminished the SMD. Exogenous NE and clonidine (1 µM
each) activated both PI3Kγ  and PKCζ , and the activation of these kinases was abolished by preincubation of tissue
with the α 2-adrenoceptor blocker yohimbine.
Conclusion:  Neuronally-released NE stimulates smooth muscle α 2-adrenoceptors and activates PI3K and
atypical PKC in the canine mesenteric vein. Events downstream of PKC lead to SMD and vasoconstriction. This
represents a novel pathway for NE-induced membrane depolarization in a vascular smooth muscle preparation.
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Background
Norepinephrine (NE), a classic neurotransmitter in the
sympathetic nervous system, is released from adrenergic
varicosities of stimulated postganglionic nerve terminals,
activates postjunctional α -adrenoceptors and gives rise to
a slow membrane depolarization (SMD) and contraction
[1,29]. The NE-induced SMD represents an important
mechanism of excitation-contraction coupling in blood
vessels however the signaling pathways underlying the
NE-elicited SMD in vascular smooth muscle remain
undefined.
One well-documented pathway downstream of activated
G-protein coupled receptors (GPCRs) includes dissocia-
tion of Gαβγ  trimers and production of Gα  monomer and
Gβγ  dimer, and involvement of the latter proteins in signal
transduction events downstream of α -adrenoceptors. For
example, Gα   mediates activation of phospholipase C
(PLC), hydrolysis of phosphatidylinositol 4,5-bisphos-
phate (PI4,5P2), and generation of second messengers
including inositol 1,4,5-triphosphate (InsP3) and diacylg-
lycerol, DAG [20]. These second messengers then mediate
signal transduction events leading to activation of ion
channels. InsP3 has the capacity to release cytosolic Ca2+
from intracellular stores, which then activates Ca2+-acti-
vated Cl- channels (ClCCa) and membrane depolarization,
required for opening of voltage-operated calcium chan-
nels (VOCC) and Ca2+ influx. DAG, on the other hand,
activates non-selective cation channels (NSCC) in rabbit
portal vein [17]. In addition, it becomes increasingly clear
that Gβγ  dimers can initiate intracellular signal transduc-
tion events as well. Phosphatidylinositol 3-kinase-γ
(PI3Kγ ), a member of class IB PI3Ks, was identified as a
major effector of Gβγ  in various cell and tissue prepara-
tions [13,18]. Lipid products of the PI3Ks, phosphatidyli-
nositol 3,4-bisphosphate (PI3,4P2) and
phosphatidylinositol 3,4,5-trisphosphate (PI3,4,5P3),
function as second messengers and can directly affect the
activity of the membrane ion channels CFTR [12] and
voltage-gated potassium channels [19]. Alternatively,
PI3,4P2 and PI3,4,5P3 can modulate membrane ion chan-
nels via activation of PKC isozymes [6,25]. For example,
Gβγ , PI3Kγ , and atypical PKC were shown to link activa-
tion of G-protein coupled M2-muscarinic receptors to
metabotropic Ca2+ and voltage-independent Cl- channels
in Xenopus oocytes [31]. It was also demonstrated that
PI3K mediates activation of L-type Ca2+ channels upon
stimulation of M2-muscarinic receptors in rabbit portal
vein myocytes [3] and α 2-adrenoceptor induced vasocon-
striction in porcine palmar lateral vein [27]. These studies
imply that activation of GPCRs could activate membrane
ion channels and SMD via PI3K-dependent mechanisms.
To our knowledge, however, coupling of α -adrenoceptors
to PI3Kγ  and membrane depolarization in vascular
smooth muscles has not yet been reported.
The α 2-adrenoceptor blocker yohimbine reduces the con- tractile responses of canine isolated mesenteric vein to nore- pinephrine (NE) and clonidine Figure 1
The α 2-adrenoceptor blocker yohimbine reduces the 
contractile responses of canine isolated mesenteric 
vein to norepinephrine (NE) and clonidine. Contractile 
responses of control and yohimbine-incubated tissues (0.1 
µM, 30 min) to exogenous NE (A) and clonidine (0.05–10 µM 
each). Contractile responses were expressed as percentage 
of the contractile response to 70 mM KCl. Data are pre-
sented as mean ± SEM, n = 4–8. *, P < 0.05. Representative 
traces of intracellular recordings of membrane potential 
changes elicited by NE (0.1 µM, 30 s, panel C) or clonidine (1 
µM, 30 s, panel D). Scale bars apply to traces C and D.
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We used canine isolated mesenteric vein to test the
hypothesis that EFS-induced SMD is mediated by PI3K
and PKC. Our results demonstrate both nerve stimulation
and exogenous NE-mediated activation of α 2-adrenocep-
tors, PI3K and PKC, and suggest a role for these kinases for
the activation of membrane ion channels (e.g., ClCCa and/
or NSCC) and development of SMD.
Results
α 2-Adrenoceptors mediate vasoconstriction and 
membrane depolarization in canine isolated mesenteric 
vein
Cumulative application of exogenous NE and clonidine
(0.05 µM-10 µM) resulted in concentration dependent
contractile responses (Fig. 1A and 1B). In the presence of
the selective α 2-adrenoceptor antagonist yohimbine (0.1
µM) the contractile responses to 0.05–1 µM NE were vir-
tually abolished, whereas the responses to 5 and 10 µM
NE were significantly reduced (Fig. 1A). Yohimbine abol-
ished the mechanical responses to all clonidine concen-
trations (Fig. 1B). These results indicate that α 2-
adrenoceptors are particularly important for NE-mediated
vasoconstriction in this blood vessel. Moreover, exoge-
nous application of either NE (0.1 µM, Fig. 1C) or cloni-
dine (1 µM, Fig. 1D) elicited SMD, suggesting that α 2-
adrenoreceptors may be involved in the membrane poten-
tial changes in response to NE that is released upon EFS.
EFS gives rise to a biphasic membrane depolarization
The resting membrane potential of isolated canine
mesenteric vein segments averaged -68.8 ± 0.8 mV (n =
78). EFS (0.1–2 Hz, 0.1 ms, 15 V, 10 s) gave rise to a char-
acteristic biphasic depolarization of the cell membrane
(Fig. 2A–E), composed of a fast excitation junction poten-
tial (EJP) of presumed purinergic nature, and a SMD of
adrenergic origin. The amplitude of the SMD increased
with the frequency of EFS (Fig. 2A–F). To better under-
stand the processes that govern membrane depolariza-
tion, we exposed blood vessels to the fast Na+ channel
blocker tetrodotoxin (TTX, 1 µM) or to the neuronal N-
type Ca2+  channel blocker ω -conotoxin GVIA (ω -CtX
GVIA, 5 nM). Both drugs virtually abolished the electrical
responses to EFS (Fig. 3A, B), suggesting that the EFS-elic-
ited SMD requires activation of postganglionic nerve ter-
minals and release of a neurotransmitter substance.
Phentolamine (1 µM) significantly reduced the SMD in
response to 0.5 Hz EFS to 2.1 ± 0.5 mV (n = 3, P < 0.05,
not shown), consistent with the possibility that NE-medi-
ated activation of α -adrenoceptors is the primary cause for
the SMD in blood vessels [14,29]. Furthermore, the selec-
tive α 2-adrenoceptor antagonist yohimbine (0.1 µM, Fig.
3C), but not the selective α 1-adrenoceptor antagonist pra-
zosin (1 µM; 8.9 ± 0.9, n = 3, not shown), significantly
reduced the SMD in response to 0.5 Hz EFS from 9.4 ± 0.7
(n = 14) to 0.8 ± 0.5 mV (n = 3, P < 0.05), indicating that
the EFS-evoked SMD is mediated primarily by α 2-adreno-
ceptors. Nicardipine (1 µM) abolished the contraction
elicited by 70 mM KCl (not shown), indicating that L-type
Ca2+ channels are present in this blood vessel. However,
the EFS-induced SMD remained unchanged in tissues pre-
incubated with nicardipine (Fig. 3D), suggesting that
opening of L-type Ca2+ channels is not required for the
membrane depolarization.
The EFS-induced slow membrane depolarization is 
sensitive to NFA, NPPB, DIDS and Gd3+
To test possible contribution of ion channels in the EFS-
induced SMD, we incubated veins with the commonly
used non-selective cation channel (NSCC) and Cl- chan-
nel inhibitors NFA (100 µM), NPPB (30 µM), and DIDS
(200 µM) [16,26]. These inhibitors reduced the 0.5 Hz
EFS-elicited SMD by 73% (Fig. 4A and 4E), 92% (Fig. 4B
and 4E) and 67% (Fig. 4C and 4E, n = 3–14), respectively.
DIDS also reduced the excitation junction potentials (Fig.
4C), which may be due to blockade of P2X receptors, as
suggested previously [2]. The NSCC inhibitor Gd3+
reduced the SMD by 60% (Fig. 4D and 4E, n = 3).
Together, our results indicate that the SMD in canine
mesenteric vein depends on activation of membrane ion
channels (e.g. ClCCa and/or NSCC).
InsP3 receptors are not required for the EFS-elicited slow 
depolarization
To determine whether EFS-induced SMD is mediated by
InsP3 receptors, veins were incubated with 2APB (50 µM),
a selective inhibitor of InsP3 receptors and hence of GPCR-
PLC-InsP3-mediated Ca2+ release from sarcoplasmic retic-
ulum. Surprisingly, SMD to 0.5 Hz EFS remained unaf-
fected by 2APB (Fig. 5A and 5C). To test the possibility
that the lack of effect of 2APB was due to poor membrane
permeability, we carried out mechanical experiments with
mesenteric veins, incubated with 2APB (50 µM) prior to
incubation with increasing concentrations of the α 1-
adrenoceptor agonist methoxamine (0.1–100 µM). 2APB
produced a significant rightward shift of the
concentration-response curve of methoxamine (not
shown) and a decrease of the EC50 from 6.2 ± 0.3 µM (n
= 10) to 5.1 ± 0.2 µM (n = 6). These results suggest that
activation of InsP3 receptors may be unnecessary for the
SMD. This possibility was also confirmed by the inability
of another inhibitor of InsP3 receptors, xestospongin C (3
µM), to reduce the EFS-evoked SMD (Fig. 5B and 5C, n =
3). Therefore, the EFS-mediated SMD may not require
release of Ca2+ from InsP3 receptor-operated stores.
PI3K blockers reduce the EFS-elicited slow depolarization
To test whether PI3Ks are involved in the EFS-induced
SMD, we incubated tissue strips with the PI3K inhibitors
wortmannin (100 nM) and LY-294002 (10 µM). Both
inhibitors significantly reduced the SMD elicited by 0.5BMC Physiology 2005, 5:9 http://www.biomedcentral.com/1472-6793/5/9
Page 4 of 16
(page number not for citation purposes)
Hz EFS from 9.4 ± 0.7 mV in controls to 1.0 ± 1.1 and 2.5
± 1.6 mV, respectively (Fig. 6), indicating that activation
of PI3Ks is required for the EFS-induced activation of ion
channels and SMD. Incubation of veins with exogenous
NE (100 nM) induced 14.1 ± 3.0 mV SMD, which was
reduced to 3.0 ± 2.0 mV (n = 3) in the presence of
wortmannin (100 nM, not shown), suggesting that both
EFS and exogenous NE-induced SMD are mediated by
PI3K.
Exogenous NE and clonidine activate PI3Ks
To determine whether NE directly activates PI3Ks, we
measured phosphorylation of Akt in control vein seg-
ments and in tissues incubated with exogenous NE (1 µM,
Typical biphasic membrane depolarization of canine isolated mesenteric vein Figure 2
Typical biphasic membrane depolarization of canine isolated mesenteric vein. Representative intracellular record-
ings depicting EFS-induced (0.1 ms, 13V, 10 s, 0.1–2 Hz) biphasic membrane depolarizations, consisting of excitatory junction 
potentials and slow membrane depolarization (A-E). The amplitude of the slow membrane depolarization increases with the 
increase of stimulation frequencies (F). Mean ± SEM, n = 4–12. Scale bars apply to traces A-E.
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Tetrodotoxin (TTX), ω -conotoxin GVIA (Ctx GVIA) and yohimbine, but not nicardipine, inhibit the EFS-induces slow mem- brane depolarization of canine isolated mesenteric vein Figure 3
Tetrodotoxin (TTX), ω -conotoxin GVIA (Ctx GVIA) and yohimbine, but not nicardipine, inhibit the EFS-
induces slow membrane depolarization of canine isolated mesenteric vein. Intracellular recordings of membrane 
potential in response to EFS (0.1 ms, 13 V, 10 s) in canine isolated mesenteric veins preincubated for 30 min prior to and 
throughout the experiment with 1 µM TTX (A), 5 nM ω -conotoxin GVIA (Ctx GVIA, B), 0.1 µM yohimbine (C) and 1 µM nica-
rdipine (D). Scale bars apply to all traces.
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The EFS-induced slow membrane depolarization of canine isolated mesenteric vein is reduced by various ion channel inhibitors Figure 4
The EFS-induced slow membrane depolarization of canine isolated mesenteric vein is reduced by various ion 
channel inhibitors. Intracellular recordings of membrane potential in response to EFS (0.1 ms, 13 V, 10 s, 0.5 Hz) in canine 
isolated mesenteric veins preincubated for 60 min prior to and throughout the experiment with 100 µM NFA (A), 30 µM 
NPPB (B), 200 µM DIDS (C) and 30 µM Gd3+ (D). The experimental data are presented as mean ± SEM, n = 3–4 (E). *, P < 0.05 
versus control. Scale bars apply to traces A-D.
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2APB and xestospongin C have no effect on the EFS-induced slow membrane depolarization of canine isolated mesenteric vein Figure 5
2APB and xestospongin C have no effect on the EFS-induced slow membrane depolarization of canine isolated 
mesenteric vein. Intracellular recordings of membrane potential in response to EFS (0.1 ms, 13 V, 10 s, 0.5 Hz) in canine iso-
lated mesenteric veins preincubated for 60 min prior to and throughout the experiment with 50 µM 2APB (A) or 30 µM xest-
ospongin C (B). The experimental data are presented as mean ± SEM, n = 3–4 (C). Scale bars apply to traces A and B.
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The PI3K inhibitors wortmannin and LY-294002 inhibit the EFS-induced slow membrane depolarization in canine isolated  mesenteric vein Figure 6
The PI3K inhibitors wortmannin and LY-294002 inhibit the EFS-induced slow membrane depolarization in 
canine isolated mesenteric vein. Intracellular recordings of membrane potential in response to EFS (0.1 ms, 13 V, 10 s) in 
canine isolated mesenteric veins preincubated for 60 min prior to and throughout the EFS with 100 nM wortmannin (A) or 10 
µM LY-294002 (B). The experimental data are presented as mean ± SEM, n = 3–4 (C). *, P < 0.05 vs control. Scale bars apply 
to traces A and B.
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3 min). Incubation with NE increased phosphorylation of
Akt about 2-fold the basal (Fig. 7A). When smooth muscle
strips were preincubated with wortmannin (100 nM, 1 h)
or LY-294002 (10 µM, 1 h), NE failed to increase phos-
phorylation of Akt. These results indicate that NE-elicited
phosphorylation of Akt in mesenteric vein requires activa-
tion of PI3Ks.
As shown in Fig. 1 and Fig 3, incubation of veins with
yohimbine significantly reduced both the NE-induced
and clonidine-induced contractions as well as the SMD
elicited by EFS. These observations raise the possibility
that the EFS and exogenous NE-induced activation of
PI3Ks may be mediated by α 2-adrenoceptors. To test this
possibility, we assayed phosphorylation of Akt (Fig. 7C)
in tissues incubated with clonidine (1 µM, 3 min) in the
absence or presence of yohimbine (0.1 µM, 1 h). Cloni-
dine alone increased phosphorylation of Akt to 2.3-fold
the basal phosphorylation and this increase was abol-
ished by inhibition of α 2-adrenoceptors with yohimbine
and by inhibition of PI3Ks with LY-294002. These data
indicate that α 2-adrenoceptors are coupled to PI3Ks and
their downstream target Akt.
Previous experiments have shown that PI3Kγ  mediates
signaling downstream of GPCRs [18,33]. To test whether
NE activates PI3Kγ , we incubated mesenteric vein with
exogenous NE, then immunoprecipitated PI3Kγ  and used
the immunoprecipitated kinase to phosphorylate phos-
phatidylinositol (PI) in vitro. As shown in Fig. 7B, stimu-
lation with NE increased the amount of PI3P (reaction
product), suggesting that NE activated PI3Kγ . NE-medi-
ated phosphorylation of PI was reversed in strips preincu-
bated with LY-294002, indicating that it was a PI3K-
dependent event. To test whether α 2-adrenoceptors are
linked to activation of PI3Kγ , we analyzed the activation
of PI3Kγ  in veins incubated with clonidine (1 µM) in the
absence or presence of yohimbine (0.1 µM). As shown in
Fig. 7D, clonidine activated PI3Kγ  to 1.8-fold the basal,
while yohimbine eliminated this activation. Thus, the
activation of PI3Ks, and more specifically PI3Kγ , by
exogenous NE and clonidine suggests that α 2-adrenocep-
tors are coupled to PI3Kγ  via activation of G-proteins.
Stimulation of atypical PKC(s) contributes to the EFS-
elicited SMD
PI3Kγ  may be linked to membrane ion channels (i.e.,
ClCCa and/or NSCC) via isozymes of the multifunctional
PKC family. To test this possibility, we incubated
mesenteric veins with the broad-spectrum PKC blocker
chelerythrine (1 µM, 1 hour). Although chelerythrine
reduced the response to 0.5 Hz EFS from 9.4 ± 0.7 mV to
2.1 ± 1.5 mV, the residual SMD remained unchanged in
veins, incubated simultaneously with LY-294002 and
chelerythrine prior to EFS (2.6 ± 1.3). These results not
only implicate the existence of a PKC-dependent compo-
nent in the EFS-induced SMD (Fig. 8A and 8C), but also
suggest that PI3Kγ  and PKC may signal to ion channels in
a linear fashion. To narrow down the PKCs that function
downstream of PI3Kγ , we used calphostin C, an inhibitor
of classical and novel PKCs [32]. One-hour incubation of
mesenteric veins with calphostin C (10 µM) failed to
inhibit EFS-stimulated SMD (Fig. 8B and 8C). However,
calphostin C significantly reduced the contractile
responses to PMA (100 nM, 30 min incubation), which is
mediated by classical and novel PKCs (not shown).
Together, these results suggest that activation of atypical,
rather than classical or novel PKC isozymes is involved in
the SMD.
Exogenous NE and clonidine activate PKCζ
Since exogenous NE and clonidine activated PI3Kγ , we
tested whether these agents also activate PKCζ , a specific
substrate of PI3Kγ  [5]. Vein segments incubated with NE
(1 µM, 3 min) and clonidine (1 µM, 3 min) caused activa-
tion of for a synthetic PKCζ  peptide substrate in vitro to
2.11 and 1.89-fold the basal kinase activity of non-stimu-
lated controls (Fig. 9A and 9B). The NE-induced activa-
tion of PKCζ  was significantly reduced in tissues
incubated with the PI3K inhibitor LY-294002 (10 µM)
and was eliminated by a specific myristoylated peptide
inhibitor of PKCζ  (PKCζ I, 50 µM)  in vitro (Fig. 9A).
Similarly, the clonidine-induced activation of PKCζ  was
eliminated in tissues preincubated with yohimbine and
LY-294002 (Fig. 9B). These results indicate that stimula-
tion of canine mesenteric veins with NE and clonidine is
associated with activation of PI3Ks and a subsequent acti-
vation of PKCζ .
Ion channel blockers and PI3K blockers do not inhibit 
release of NE
Reduction of the SMD could be the result of suppressed
NE release from sympathetic nerve terminals in veins,
incubated with protein kinase and ion channel blockers.
To test this possibility, we assayed the EFS-evoked release
of NE in superfusates collected during EFS in control veins
and in tissues preincubated with each of the aforemen-
tioned blockers. The average EFS -evoked overflow of NE
in tissue controls (16 Hz, 0.1 ms) was 122 ± 27 fmol/mg
(n = 17). In preincubated tissues, the overflow of NE
changed to (fmol/mg tissue) 236 ± 40 in the presence of
NFA (n = 6), 480 ± 122 by NPPB (n = 6), 142 ± 2 by DIDS
(n = 6), 144 ± 5 by wortmannin (n = 5), and 214 ± 38 by
LY-294002 (n = 7). Therefore, none of these agents
reduced the EFS-evoked overflow of NE, indicating that
their effects on the EFS-induced SMD are not due to
inhibited NE release but to activation of postjunctional
(i.e., smooth muscle) mechanisms.BMC Physiology 2005, 5:9 http://www.biomedcentral.com/1472-6793/5/9
Page 10 of 16
(page number not for citation purposes)
Exogenous NE and clonidine activate PI3Ks in canine isolated mesenteric vein Figure 7
Exogenous NE and clonidine activate PI3Ks in canine isolated mesenteric vein. Immunoblots of Akt and phospho-
Akt (P-Akt) in untreated control tissues (CT), and in tissues treated with NE (1 µM, 3 min) alone or after 60-min preincubation 
with 100 nM wortmannin, Wm, or 10 µM LY-294002, LY (A). Immune blots of P-Akt in veins incubated with clonidine (1 µM, 
3 min) in the absence or after 60-min preincubation with 0.1 µM yohimbine, Yoh (C). The phospho-Akt (P-Akt) band densities 
were normalized to the respective Akt band densities, and the P-Akt/Akt ratios of treated tissues were presented relative to 
the ratios of non-treated tissue controls (bar graphs in A and C, n = 3). Thin-layer chromatography (TLC) separation of PI3P, 
obtained upon in vitro phosphorylation of PI by immunoprecipitated PI3Kγ . PI3Kγ  activation was assessed in untreated (control) 
tissue (CT) and in tissues incubated for 3 min with 1 µM NE (B) or 1 µM clonidine (D), without or after 1-h preincubation with 
LY-294002 (LY, 10 µM) or yohimbine (Yoh, 0.1 µM). Phosphorylated PIP3 was quantified by radiography and densitometry, and 
PI3Kγ  activation in treated tissues was expressed relative to non-treated tissue controls (bar graph, n = 3). *, P < 0.05 versus 
controls, #, P < 0.05 versus veins treated with NE or clonidine.
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The PKC inhibitor chelerythrine, but not calphostin C, reduces the EFS-evoked slow membrane depolarization in canine iso- lated mesenteric vein Figure 8
The PKC inhibitor chelerythrine, but not calphostin C, reduces the EFS-evoked slow membrane depolariza-
tion in canine isolated mesenteric vein. Intracellular recordings of membrane potential in response to EFS (0.1 ms, 13V, 
10 s, 0.5 Hz) in control mesenteric veins (Control) or in tissues preincubated for 60 min with 1 µM chelerythrine (A) or 10 µM 
calphostin C (Calph C, B). The experimental data are presented as mean ± SEM, n = 3. *, P < 0.05 versus control. Scale bars 
apply to traces A and B.
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Discussion
The NE-induced membrane depolarization is an essential
requirement for opening VOCC, Ca2+ entry and smooth
muscle contraction, and hence it represents an important
mechanism of autonomic neurovascular control. Previous
studies [4] as well as the present work indicate that α 2-
adrenoceptors are involved in the SMD and the vasocon-
striction of mesenteric vein. However, the downstream
mechanisms that couple α 2-adronoceptors to SMD
remain undefined. For example, NE-induced activation of
ClCCa plays a key role in the associated vasoconstriction
and presumed membrane depolarization in various vas-
cular networks [11,16], but NSCC may also participate in
the NE-induced vasoconstriction [17]. In the present
study, we have expanded upon these previous works by
directly measuring membrane potential in response to
EFS of intact canine isolated mesenteric veins. We found
that the SMD in response to EFS is frequency-dependent,
and is sensitive to the fast Na+ channel blocker TTX, to the
inhibitor of neuronal N-type Ca2+ channels ω -conotoxin
GVIA [24], and to the selective antagonist of α 2-adreno-
ceptors yohimbine. Consistent with previous works,
therefore, our results indicate that EFS gives rise to a SMD,
which is mediated by smooth muscle α 2-adrenoceptors
and hence is primarily mediated by NE, released upon
action potential. Furthermore, the SMD of the vascular
smooth muscle cell membrane appears to be mediated by
channels sensitive to NFA, NPPB, and DIDS. Although
these inhibitors target transporters with presumed high
preference for Cl- [8], they may also affect other ion chan-
nels, such as the inhibition of NSCC by DIDS [7]. Because
incubation of mesenteric veins with the NSCC blocker
Gd3+ partially reduced the EFS-evoked SMD, our results
suggest that activation of NSCC may indeed contribute to
the EFS-elicited SMD in this blood vessel. None of the
channel blockers reduced the release of NE thus demon-
strating that the decrease of SMD is mediated by postjunc-
tional smooth muscle mechanisms. The EFS-induced
SMD remained unaffected by the InsP3 receptor inhibitors
2APB and xestospongin C, ruling out a substantial role of
InsP3  receptor-mediated Ca2+  release in this response.
Therefore, smooth muscle cell chloride channels and/or
NE and clonidine activate PKCζ  in canine mesenteric vein Figure 9
NE and clonidine activate PKCζ  in canine mesenteric vein. Phosphorylation of a specific PKCζ  peptide substrate 
(PKCζ PS) in vitro by total protein extracts obtained from untreated controls (CT) and tissues incubates for 3 min with 1 µM 
NE (A) or 1 µM clonidine (B), without or after 60-min preincubation with LY-294002 (10 µM), myristoylated PKCζ  peptide 
inhibitor (PKCζ I, 50 µM) or yohimbine (Yoh, 0.1 µM). Phosphorylation of the PKCζ  PS (i.e. density of the phospho-PS dots) 
was quantitated by radiography and densitometry (insets). Phosphorylation of PKCζ SP in treated tissues is presented relative 
to non-treated tissue controls (bar graph, n = 3). *, P < 0.05 versus control; #, P < 0.05 versus veins treated with NE or 
clonidine.
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NCSS appear to be the primary activities that mediate the
SMD in the canine mesenteric vein.
Furthermore, we identified a novel signal transduction
mechanism governing the slow membrane depolariza-
tion, which involves enzymes of the PKC family. First, we
used two PKC inhibitors with distinct PKC isozymes selec-
tivity. Chelerythrine, for example, acts on the conserved
catalytic domain of PKC as a competitive inhibitor with
respect to the phosphate acceptor and a non-competitive
inhibitor with respect to ATP [32]. Therefore, cheleryth-
rine can inhibit PKCs of all classes and effects mediated by
them, including the slow depolarization in mesenteric
veins. In contrast, calphostin C interacts with the regula-
tory domain of PKC by competing for the binding site of
diacylglycerol and phorbol esters, but not Ca2+ and phos-
pholipids. Thus, calphostin C is more specific inhibitor
for classical and novel, and less specific for atypical PKC
[9,32]. In the present study, chelerythrine reduced, while
calphostin C had no effect on the SMD. The lack of effect
of calphostin C indicates that the EFS-induced membrane
depolarization is most likely mediated by atypical PKC(s).
We provided experimental support of this possibility by
showing a distinct activation of the atypical PKCζ  in
mesenteric veins incubated with exogenous NE and cloni-
dine. Although further studies are needed to identify the
precise PKC isoform(s) contributing to the α 2-adrenocep-
tor mediated SMD, the present study clearly suggests a
PKC isozyme-specific regulation of the EFS- (and hence
NE-) induced slow membrane depolarization in canine
mesenteric vein.
The observation that atypical PKCs are involved in the
SMC allowed us to speculate about the identity of some
specific signaling molecules that function upstream of
PKCζ , and could mediate the SMD as well. PI3Ks, and par-
ticularly PI3Kγ , was an obvious candidate for several rea-
sons. Firstly, PI3Kγ  is essential for activation of various ion
transporters including L-type Ca2+  channels [30] and
metabotropic nonselective cation channels [31]. Sec-
ondly, PI3Kγ  activates the phosphoinositide-dependent
protein kinase 1 (PDK1), and although the latter can
modulate classical (α  and β I) and novel (δ  and ε ) PKC iso-
form, activation of atypical (ζ /λ /τ ) PKCs, and particularly
PKCζ , is a highly specific event downstream of PI3Kγ -
PDK1 [28]. We experimentally supported the hypothe-
sized role of PI3Ks by showing that the PI3K inhibitors
wortmannin and LY-294002 prevent the NE and cloni-
dine-dependent activation of PKCζ  and the SMD. These
data are consistent with a role of PI3K in the regulation of
voltage-independent Cl- channels, as well. PI3Kγ  in partic-
ular is activated by Gβγ  dimers, which are released upon
dissociation of Gαβγ  complexes following activation of
GPCRs [18]. Our experimental data demonstrate activa-
tion of PI3Kγ  in veins incubated with the G-protein cou-
pled  α 2-adrenoceptor agonists NE and clonidine.
Furthermore, since the NE and clonidine-mediated activa-
tion of PI3Kγ , PKCζ  and of the SMD was prevented by
yohimbine, our results demonstrate that activation of α 2-
adrenoceptors is required for activation of PI3Kγ  and
PKCζ , and possibly for activation of membrane Cl- and/or
NCSS channels and SMD in canine mesenteric vein. While
the molecular identity of the membrane ion channels
involved in these effects is presently elusive, our electro-
physiological and biochemical data provide support to
the possibility that activation of α 2-adrenoceptors, PI3K
and atypical PKC (possibly PKCζ ) is essential for the reg-
ulation of the autonomic nervous system and vascular
smooth muscle tone.
Conclusion
In this study we provide functional and biochemical evi-
dence that NE, released from postganglionic nerve termi-
nals, activates postjunctional α 2-adrenoceptors, PI3Ks
and atypical PKCs in canine isolated mesenteric vein. Our
results further suggest that specific isoforms of the PI3K
and PKC families, i.e. PI3Kγ  and PKCζ  respectively, may
participate in the signal transduction pathway that
couples  α 2-adrenoceptors to membrane ion channels.
This signal transduction pathway mediates slow mem-
brane depolarization and vasoconstriction of canine
mesenteric vein.
Methods
Tissue preparation
Seventy-four mongrel dogs of either sex (averaging 15 kg)
were obtained from vendors licensed by the United States
Department of Agriculture. The use of dogs was approved
by the University of Nevada's Animal Care and Use Com-
mittee. The animals were sacrificed with an overdose of
pentobarbitone sodium (100 mg/kg intravenously), as
recommended by the Panel on Euthanasia of the Ameri-
can Veterinary Medical Association. Experiments were
conducted with second and third order branches of the
inferior mesenteric vein (0.7–1.2 mm in diameter), dis-
sected and denuded of endothelium as outlined previ-
ously [21].
Intracellular recording of membrane potential
Ring segments (7–10 mm long; 700–800 µM external
diameter) were pinned out on the sylgard bottom of a 2
ml recording chamber perfused with Krebs solution (3
ml/min; 37°C; aerated with 95% O2/5% CO2) with the
following composition (mM): 150 NaCl, 4.6 KCl, 1.2
MgCl2, 2.5 CaCl2, 24.8 NaHCO3, 1.2 KH2PO4 and 5.6
dextrose. Intracellular measurements were made through
the adventitia of the vessel with fiber-containing
borosilicate electrodes filled with 3 M KCl (70–100 MΩ
resistance), as described previously [22]. EFS at supramax-
imal voltage with trains of square-wave pulses (0.1 msBMC Physiology 2005, 5:9 http://www.biomedcentral.com/1472-6793/5/9
Page 14 of 16
(page number not for citation purposes)
pulse width) was applied at 0.1–2 Hz for 10 s by means of
two parallel platinum electrodes on both sides of the ves-
sel connected to a Grass S48 stimulator. Once well-
defined and reproducible slow depolarizations were
obtained, various drugs were applied to the superfusion
solution according to the experimental protocol. The
maximum depolarization was evaluated.
The effects of NFA (100 µM), NPPB (30 µM), DIDS (200
µM), 2 APB (50 µM), and xestospongin C (3 µM) were
examined by recording membrane potential in response
to EFS before and 30-min after the tissue was superfused
with the drug. To assess the role of PI3K and PKC or the
NSCC, tissues were superfused with wortmannin (100
nM), LY 294002 (10 µM), chelerythrine (1 µM), calphos-
tin C (10 µM) or Gd3+ (30 µM) for 60 min prior to the EFS.
To produce appropriate time controls, EFS-mediated SMD
were recorded periodically for 2–4 h in tissues not
incubated with inhibitors. In some experiments tissues
were perfused with NE (100 nM) for 30 s to induce SMD
and changes in this response were monitored in the
absence and presence of wortmannin (100 nM). In some
experiments tissues were perfused with clonidine (1 µM)
and changes in the membrane potential were monitored.
Transmitter release experiments and HPLC assay of NE
Segments of endothelium-denuded mesenteric veins
(52.5 ± 3.2 mg wet weight, n = 30) were placed in 200-µl
BRANDEL superfusion chambers as previously described
[23]. After 45 min equilibration, the tissues were sub-
jected to a 30-seconds "conditioning" stimulation with a
train of square wave pulses of 0.3 ms duration and a fre-
quency of 4 Hz. Thirty minutes later the blood vessels
were subjected to EFS for 60 s with a train of suprathresh-
old pulses of 0.1 ms duration at 16 Hz. Samples of the
superfusion solution were collected before the electrical
stimulation (resting overflow) and during  the electrical
stimulation (electrically evoked overflow) in ice-cold test
tubes. Samples were analyzed for NE content by high per-
formance liquid chromatography (HPLC) technique in
conjunction with electrochemical detection [23].
After the equilibration period the tissues were superfused
either with wortmannin (100 nM), or LY-294002 (10
µM), or chelerythrine (1 µM), or calphostin C (10 µM) for
60 min prior to EFS. In some experiments tissues were
superfused with NFA (100 µM), NPPB (30 µM), or DIDS
(200 µM) for 30 min prior to EFS. Only one drug was
tested in each tissue.
Mechanical responses
Ring preparations (3 mm long) were mounted in 3 ml
organ baths by inserting two stainless steel triangle
mounts into the lumen, and force displacements were fur-
ther investigated as described previously [21]. The baths
contained Krebs solution, which routinely contained
indomethacin (1 µM) and Nω -nitro-L-arginine (l-NNA,
100  µM) to block potential residual effects of the
endothelium and to eliminate possible time dependent
effects due to activation of inducible nitric oxide synthase
(iNOS) and/or cyclooxygenase. Thus, the contractile
responses to KCl and nerve stimulation were reproducible
over many hours when these blockers were included in
the bathing solution. A resting force of 0.5 g was applied
to the vein segments. This was found to stretch vessels to
near the optimum length for tension development. After
equilibrating the tissues [21], concentration-response
relationships were obtained by cumulative addition of
increasing concentrations of the α 1-adrenoceptor agonist
methoxamine in the absence and presence of 2APB (50
µM, 30 min pretreatment). Contractile responses elicited
by methoxamine, NE and clonidine were expressed as a
percentage of the contractile response produced with 70
mM KCl. The 70 mM KCl solution had the following com-
position (mM): 84.6 NaCl, 70 KCl, 1.2 MgCl2, 2.5 CaCl2,
24.8 NaHCO3, 1.2 KH2PO4 and 5.6 dextrose. Control
experiments were carried out to determine the consistency
of the contractile response to repeated applications of KCl
(70 mM) over the duration of an average treatment proto-
col. The relative potency of methoxamine was determined
by the concentration producing half-maximal effect. In
some experiments, the effect of KCl (70 mM) was tested in
the presence of nicardipine (1 µM). In other experiments,
tissues were contracted with phorbol 12-myristate 13-ace-
tate (PMA, 100 nM) in the absence or presence of cheler-
ythrine (1 µM) or calphostin C (10 µM). In some
experiments contractile responses to either exogenous NE
or clonidine (both 0.05–10 µM) were monitored in the
absence or presence of yohimbine (0.1 µM for 30 min).
Preparation of tissue homogenates and cytosolic fractions
Total protein extracts were prepared by glass-glass homog-
enization of mesenteric veins, pulverized under liquid
nitrogen, with a buffer composed of (mM): 10 Tris-HCl
(pH 7.4), 5 EDTA, 5 EGTA, 10 sodium pyrophosphate, 10
NaF, 1 sodium orthovanadate, 0.1 AEBSF and 0.001 leu-
peptin. Insoluble material was pelleted by centrifugation
at 3,000 g (S3 supernatants) for 5 min at 4°C. S3 superna-
tants were transferred into clean tubes and centrifuged at
120,000 g for 60 min at 4°C to obtain S120 supernatants,
which were used for assay of PI3K and PKC activity.
PI3K activation assay
Activation of PI3K was assayed by the phosphorylation of
the downstream protein kinase Akt. Equal amounts of
total supernatant protein (30 µg) were resolved by SDS-
PAGE, transferred onto nitrocellulose membranes, and
total and phospho-Ser473-Akt were assayed by immuno-
blotting, using a rabbit polyclonal or mouse monoclonal
antibodies, respectively. Blots were scanned to obtainBMC Physiology 2005, 5:9 http://www.biomedcentral.com/1472-6793/5/9
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images and the immunoreactive bands were analyzed by
densitometry, using the Quantity One software (BioRad).
Changes in protein phosphorylation were calculated by
normalizing the band density phospho-Akt to total Akt,
and then were presented relative to the untreated group
controls.
PI3Kγ  activation assay
PI3Kγ  was immunoprecipitated from S120 supernatants
with a mouse monoclonal antibody, immobilized on Pro-
tein A/G agarose plus beads (Santa Cruz Biotechnology,
Inc.). Kinase activity was assayed by phosphorylation of
phosphatidylinositol (PI) in vitro, as described previously
[34].
PKCζ  activation assay
PKCζ  activation was assayed by in vitro phosphorylation
of a synthetic peptide substrate (PKCζ PS),
ERMRPRKRQGSVRRRV [15]. S120 fractions from control
and treated tissues were used as enzyme sources. The
phosphorylation reactions were stopped by cooling on
ice, and 10 µl reactions were spotted on P81 filter strips.
Excess radioactivity was removed from the filters by 3
washes with 75 mM ortho-phosphoric acid and a final
wash with ethanol. The filters were air-dried prior to radi-
ography and spots were quantified by densitometry, using
a BioRad Model 525 Molecular Imager. In order to verify
PKCζ -specific phosphorylation of the substrate, in some
phosphorylation reactions we added a specific myris-
toylated PKCζ  peptide inhibitor (PKCζ I, 50 µM,
Calbiochem).
Drugs
NFA, NPPB, wortmannin, LY 294002, DIDS, nicardipine,
norepinephrine hydrochloride, tetrodotoxin, phen-
tolamine, xestospongin C, gadolinium chloride, PMA
(Sigma-Aldrich), 2 APB (Tocris), PKCζ PS and PKCζ I (Cal-
biochem), chelerythrine, calphostin C (Biomol), general
and phospho-specific anti-Akt antibodies (Cell Signaling
Technology, Inc.), phosphatidylinositol (PI, Avanti).
Gadolinium solutions were prepared fresh each day,
essentially as described elsewhere [10]. Wortmannin, LY-
294002, chelerythrine, calphostin C, PMA were dissolved
in dimethylsulfoxide (DMSO) and diluted in double dis-
tilled water or Krebs solution. The final concentration of
DMSO was less than 0.1 % DMSO.
Statistical analysis
Data are presented as means ± SEM. Means were com-
pared by analysis of variance (one-way ANOVA) (Graph-
PadPrism v. 3, GraphPad Software, Inc.). A probability
value of less than 0.05 was considered significant. In the
intracellular recording and mechanical response experi-
ments, n refers to the number of rings, and hence dogs,
included in each experimental group.
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